Literature DB >> 21703205

Treatment of newborn G6pc(-/-) mice with bone marrow-derived myelomonocytes induces liver repair.

Roberta Resaz1, Laura Emionite, Cristina Vanni, Simonetta Astigiano, Maura Puppo, Rosa Lavieri, Daniela Segalerba, Annalisa Pezzolo, Maria Carla Bosco, Alessandra Oberto, Carola Eva, Janice Y Chou, Luigi Varesio, Ottavia Barbieri, Alessandra Eva.   

Abstract

BACKGROUND & AIMS: Several studies have shown that bone marrow-derived committed myelomonocytic cells can repopulate diseased livers by fusing with host hepatocytes and can restore normal liver function. These data suggest that myelomonocyte transplantation could be a promising approach for targeted and well-tolerated cell therapy aimed at liver regeneration. We sought to determine whether bone marrow-derived myelomonocytic cells could be effective for liver reconstitution in newborn mice knock-out for glucose-6-phosphatase-α.
METHODS: Bone marrow-derived myelomonocytic cells obtained from adult wild type mice were transplanted in newborn knock-out mice. Tissues of control and treated mice were frozen for histochemical analysis, or paraffin-embedded and stained with hematoxylin and eosin for histological examination or analyzed by immunohistochemistry or fluorescent in situ hybridization.
RESULTS: Histological sections of livers of treated knock-out mice revealed areas of regenerating tissue consisting of hepatocytes of normal appearance and partial recovery of normal architecture as early as 1 week after myelomonocytic cells transplant. FISH analysis with X and Y chromosome paints indicated fusion between infused cells and host hepatocytes. Glucose-6-phosphatase activity was detected in treated mice with improved profiles of liver functional parameters.
CONCLUSIONS: Our data indicate that bone marrow-derived myelomonocytic cell transplant may represent an effective way to achieve liver reconstitution of highly degenerated livers in newborn animals.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703205      PMCID: PMC6541203          DOI: 10.1016/j.jhep.2011.02.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  32 in total

1.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.

Authors:  E Lagasse; H Connors; M Al-Dhalimy; M Reitsma; M Dohse; L Osborne; X Wang; M Finegold; I L Weissman; M Grompe
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

2.  Kinetics of liver repopulation after bone marrow transplantation.

Authors:  Xin Wang; Eugenio Montini; Muhsen Al-Dhalimy; Eric Lagasse; Milton Finegold; Markus Grompe
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

3.  Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs.

Authors:  Lingfei Xu; Mark E Haskins; John R Melniczek; Cuihua Gao; Margaret A Weil; Thomas M O'Malley; Patricia A O'Donnell; Hamutal Mazrier; N Matthew Ellinwood; Jean Zweigle; John H Wolfe; Katherine Parker Ponder
Journal:  Mol Ther       Date:  2002-02       Impact factor: 11.454

4.  Correction of glycogen storage disease type 1a in a mouse model by gene therapy.

Authors:  A Zingone; H Hiraiwa; C J Pan; B Lin; H Chen; J M Ward; J Y Chou
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

5.  Transplanted bone marrow regenerates liver by cell fusion.

Authors:  George Vassilopoulos; Pei-Rong Wang; David W Russell
Journal:  Nature       Date:  2003-03-30       Impact factor: 49.962

6.  Cell fusion is the principal source of bone-marrow-derived hepatocytes.

Authors:  Xin Wang; Holger Willenbring; Yassmine Akkari; Yumi Torimaru; Mark Foster; Muhsen Al-Dhalimy; Eric Lagasse; Milton Finegold; Susan Olson; Markus Grompe
Journal:  Nature       Date:  2003-03-30       Impact factor: 49.962

7.  Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.

Authors:  H Hiraiwa; C J Pan; B Lin; S W Moses; J Y Chou
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

8.  Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs.

Authors:  Katherine Parker Ponder; John R Melniczek; Lingfei Xu; Margaret A Weil; Thomas M O'Malley; Patricia A O'Donnell; Van W Knox; Gustavo D Aguirre; Hamutal Mazrier; N Matthew Ellinwood; Meg Sleeper; Albert M Maguire; Susan W Volk; Robert L Mango; Jean Zweigle; John H Wolfe; Mark E Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

9.  Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.

Authors:  Mao-Sen Sun; Chi-Jiunn Pan; Jeng-Jer Shieh; Abhijit Ghosh; Li-Yuan Chen; Brian C Mansfield; Jerrold M Ward; Barry J Byrne; Janice Yang Chou
Journal:  Hum Mol Genet       Date:  2002-09-01       Impact factor: 6.150

10.  The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo.

Authors:  Frank Park; Kazuo Ohashi; Mark A Kay
Journal:  Mol Ther       Date:  2003-08       Impact factor: 11.454

View more
  6 in total

1.  Donor-derived hepatocytes in human hematopoietic cell transplant recipients: evidence of fusion.

Authors:  David Myerson; Rachael K Parkin
Journal:  Virchows Arch       Date:  2018-12-12       Impact factor: 4.064

Review 2.  Liver transplantation in glycogen storage disease type I.

Authors:  Susanna J B Boers; Gepke Visser; Peter G P A Smit; Sabine A Fuchs
Journal:  Orphanet J Rare Dis       Date:  2014-04-09       Impact factor: 4.123

3.  Development of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-α deficiency.

Authors:  Roberta Resaz; Cristina Vanni; Daniela Segalerba; Angela R Sementa; Luca Mastracci; Federica Grillo; Daniele Murgia; Maria Carla Bosco; Janice Y Chou; Ottavia Barbieri; Luigi Varesio; Alessandra Eva
Journal:  Dis Model Mech       Date:  2014-09       Impact factor: 5.758

4.  Veratrilla baillonii Franch Ameliorates Diabetic Liver Injury by Alleviating Insulin Resistance in Rats.

Authors:  Zhi-Hao Zhang; Juan Li; Jun Li; Zhaowu Ma; Xian-Ju Huang
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

5.  Human Umbilical Cord Blood Mononuclear Cells Ameliorate CCl4-Induced Acute Liver Injury in Mice via Inhibiting Inflammatory Responses and Upregulating Peripheral Interleukin-22.

Authors:  Jinming Zhang; Hengben Zhai; Pei Yu; Dabao Shang; Ruidong Mo; Ziqiang Li; Xiaolin Wang; Jie Lu; Qing Xie; Xiaogang Xiang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

6.  Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model.

Authors:  Lu Li; Zhutian Zeng; Ziping Qi; Xin Wang; Xiang Gao; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.